Tampa, Fla.-based Moffitt Cancer Center recorded an operating income of $63.7 million (7.3% operating margin) during the third quarter of fiscal 2026, up from $40.2 million (5.2% margin) during the same period last year, according to its May 6 financial report.
For the three months ended March 31, Moffitt reported total operating revenue of $868.4 million, a 12.8% increase year over year. Patient service revenue increased 12.4% to $746.8 million.
Total operating expenses were $804.7 million in the third quarter of 2026, a 10.2% increase year over year. Salaries, wages and benefits increased 10.3% to $357.9 million. Supply expenses increased 11.6% year over year to $312.2 million. Purchased services increased 10.5% to $64.4 million.
Moffitt reported a net income of $60.9 million in the third quarter of 2026, up from $52.4 million during the same period last year.
For the nine months ended March 31, Moffitt reported an operating income of $174.8 million (6.9% operating margin), up from $73.7 million (3.4% margin) during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
